TeamViewer AG buy Biotechhunter
Summary
This prediction ended on 11.06.20 with a price of €43.51. With a performance of -3.36%, the BUY prediction by Biotechhunter finished with a loss. Biotechhunter has 50% into this predictionTeamViewer is a publicly listed German software company that provides remote access and online meeting solutions to businesses and individuals worldwide. Their software allows users to remotely access, control and manage computers, servers, and mobile devices from anywhere, at any time. TeamViewer is used by businesses of all sizes, including tech startups and global corporations, to streamline IT operations, enhance collaboration and communication among teams, and improve customer service. In addition, the company offers a range of subscription plans and licenses to suit different business needs and budgets.
Performance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
TeamViewer AG | -1.176% | -1.176% | -29.210% | -57.303% |
iShares Core DAX® | 1.056% | 1.056% | 18.108% | 16.006% |
iShares Nasdaq 100 | -1.886% | -0.160% | 26.970% | 36.233% |
iShares Nikkei 225® | 2.553% | 4.359% | 17.676% | 10.955% |
iShares S&P 500 | -0.434% | 0.224% | 24.986% | 37.667% |
Comments by Biotechhunter for this prediction
In the thread Teamviewer AG diskutieren
In the thread Trading TeamViewer AG